Product Images Alendronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Alendronate Sodium NDC 68071-4120 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 4120 01 a161

pdp - 68071 4120 01 a161

This is a description of a medication called Alendronate Sodium 70mg, which comes in a pack of 12 tablets. The medication is being produced by NuCare Pharmaceuticals, Inc. The lot number for this batch is 000000, and the expiration date is 00-00. The National Drug Code (NDC) for this medication is 68071-4120-1. The pack also includes a warning to keep it out of the reach of children, and a note to store it at a controlled temperature of 59-36 °F.*

Structural formula for Alendronate Sodium - alendronate sodium tablets 3

Structural formula for Alendronate Sodium - alendronate sodium tablets 3

Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT (patients with radiographic vertebral fracture at baseline) - alendronate sodium tablets 4

Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT (patients with radiographic vertebral fracture at baseline) - alendronate sodium tablets 4

Osteoporosis Treatment Studies in Postmenopausal Women Increase in BMD Alendronate Sodium 10 mg/day at Three Years - alendronate sodium tablets 5

Osteoporosis Treatment Studies in Postmenopausal Women Increase in BMD Alendronate Sodium 10 mg/day at Three Years - alendronate sodium tablets 5

Osteoporosis Treatment Studies in Postmenopausal Women Time Course of Effect of Alendronate Sodium 10 mg/day Versus Placebo: Lumbar Spine BMD Percent Change From Baseline - alendronate sodium tablets 6

Osteoporosis Treatment Studies in Postmenopausal Women Time Course of Effect of Alendronate Sodium 10 mg/day Versus Placebo: Lumbar Spine BMD Percent Change From Baseline - alendronate sodium tablets 6

Osteoporosis Prevention Studies in Postmenopausal Women - alendronate sodium tablets 7

Osteoporosis Prevention Studies in Postmenopausal Women - alendronate sodium tablets 7

Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year - alendronate sodium tablets 8

Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year - alendronate sodium tablets 8

Studies in Paget’s Disease of Bone Effect on Serum Alkaline Phosphatase of Alendronate Sodium 40 mg/day Versus Placebo or Etidronate 400 mg/day - alendronate sodium tablets 9

Studies in Paget’s Disease of Bone Effect on Serum Alkaline Phosphatase of Alendronate Sodium 40 mg/day Versus Placebo or Etidronate 400 mg/day - alendronate sodium tablets 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.